May 2024 Spotlight On German Exchange Growth Companies With High Insider Ownership
As of May 2024, the German market exhibits a stable demeanor amidst fluctuating global economic signals, with the DAX index showing minimal changes in a week marked by diverse international market performances. In this context, growth companies with high insider ownership in Germany may offer unique investment perspectives due to the alignment of management interests with shareholder values, potentially enhancing company performance and investor confidence during uncertain times.
Top 10 Growth Companies With High Insider Ownership In Germany
Name | Insider Ownership | Earnings Growth |
pferdewetten.de (XTRA:EMH) | 26.8% | 73.5% |
Deutsche Beteiligungs (XTRA:DBAN) | 35.3% | 31.6% |
YOC (XTRA:YOC) | 24.8% | 22.1% |
NAGA Group (XTRA:N4G) | 14.1% | 58.1% |
Exasol (XTRA:EXL) | 25.3% | 107.4% |
Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
Stratec (XTRA:SBS) | 30.9% | 22% |
elumeo (XTRA:ELB) | 25.8% | 99.1% |
Friedrich Vorwerk Group (XTRA:VH2) | 18% | 29.9% |
Redcare Pharmacy (XTRA:RDC) | 17.7% | 46.9% |
Let's explore several standout options from the results in the screener.
Brockhaus Technologies
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Brockhaus Technologies AG operates as a private equity firm with a market capitalization of approximately €283.13 million.
Operations: The firm functions in the private equity sector, with a market capitalization of about €283.13 million.
Insider Ownership: 26.6%
Revenue Growth Forecast: 17.8% p.a.
Brockhaus Technologies is poised for notable growth with expected revenue increases of 17.8% annually, outpacing the German market's 5.3%. Despite trading significantly below its estimated fair value, the firm faces challenges with a recent shift from profit to a net loss of €3.34 million in 2023 and an even larger loss in Q1 2024. However, it forecasts strong organic revenue growth between €220 million and €240 million for 2024, signaling potential recovery and expansion efforts.
Hypoport
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Hypoport SE is a technology-based financial service provider in Germany, with a market capitalization of approximately €2.19 billion.
Operations: The company's revenue is primarily generated through its Credit Platform and Insurance Platform, which contributed €155.60 million and €66.29 million respectively.
Insider Ownership: 35.1%
Revenue Growth Forecast: 12.6% p.a.
Hypoport SE, a growth-oriented company with high insider ownership in Germany, has demonstrated robust financial performance with a significant increase in earnings by 240.5% over the past year. The company's revenue and earnings are expected to continue outpacing the German market, with forecasts of 12.6% and 35.9% annual growth respectively. Despite these strengths, its Return on Equity is anticipated to remain low at 9.1%. Recent presentations and positive quarterly results underscore its ongoing momentum and market confidence.
Delve into the full analysis future growth report here for a deeper understanding of Hypoport.
The valuation report we've compiled suggests that Hypoport's current price could be inflated.
Redcare Pharmacy
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV is a company that operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market capitalization of €2.37 billion.
Operations: The company generates €1.62 billion from its DACH region operations and €0.37 billion internationally.
Insider Ownership: 17.7%
Revenue Growth Forecast: 17% p.a.
Redcare Pharmacy NV, while trading 41% below its estimated fair value, shows promise with expected profitability within three years and a forecasted revenue growth of 17% per year, outpacing the German market's 5.3%. Despite recent earnings showing a reduction in net loss from EUR 10.22 million to EUR 7.81 million and substantial sales growth, shareholder dilution over the past year and low forecasted Return on Equity at 12.9% present challenges. The company anticipates robust sales between EUR 2.3 billion to EUR 2.5 billion for 2024, reflecting a significant growth potential.
Click to explore a detailed breakdown of our findings in Redcare Pharmacy's earnings growth report.
Our valuation report here indicates Redcare Pharmacy may be overvalued.
Seize The Opportunity
Delve into our full catalog of 16 Fast Growing German Companies With High Insider Ownership here.
Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.
Interested In Other Possibilities?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include XTRA:BKHT XTRA:HYQ and XTRA:RDC.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com